Evidence map›Paper›PMID 22706078›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Platelets present antigen in the context of MHC class I.

Lesley M Chapman, Angela A Aggrey, David J Field, Kalyan Srivastava, Sara Ture, Katsuyuki Yui, David J Topham, William M Baldwin, Craig N Morrell

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed.

  1. Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Platelet effector functions in inflammation.Research and practice in thrombosis and haemostasis · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Beyond hemostasis, the immunomodulatory nature of platelets.Research and practice in thrombosis and haemostasis · 2025
    Review
  15. Article
  16. Natural killer cell granule protein 7 contributes to CD8Research and practice in thrombosis and haemostasis · 2025
    Article
  17. Review
  18. Article
  19. Review
  20. Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lesley M ChapmanAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Angela A Aggrey
David J Field
Kalyan Srivastava
Sara Ture
Katsuyuki Yui
David J Topham
William M Baldwin
Craig N Morrell

Funding

Surgery CoreP01AI087586 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI VALUJSKIKH, ANNA · 2010 to 2019
$17.2M
The University of Rochester's Clinical and Translational Science InstituteTL1RR024135 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$3.7M
The Role of Platelets in Alloantibody Mediated Transplant RejectionR01HL093179 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2008 to 2012
$2.2M
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate ReceptorR01HL094547 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2009 to 2012
$1.6M
The University of Rochester Clinical and Translational Science InstituteTL1TR000096 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$930k
NCRR NIH HHS TL1 RR024135NHLBI NIH HHS R01 HL093179NHLBI NIH HHS R01HL093179NHLBI NIH HHS R01HL093179-02S109NHLBI NIH HHS R01 HL094547NHLBI NIH HHS R01HL094547NIAID NIH HHS P01 AI087586NIAID NIH HHS P01AI087586
6 · The paper itself

Abstract

Platelets are most recognized for their vital role as the cellular mediator of thrombosis, but platelets also have important immune functions. Platelets initiate and sustain vascular inflammation in many disease conditions, including arthritis, atherosclerosis, transplant rejection, and severe malaria. We now demonstrate that platelets express T cell costimulatory molecules, process and present Ag in MHC class I, and directly activate naive T cells in a platelet MHC class I-dependent manner. Using an experimental cerebral malaria mouse model, we also demonstrate that platelets present pathogen-derived Ag to promote T cell responses in vivo, and that platelets can be used in a cell-based vaccine model to induce protective immune responses. Our study demonstrates a novel Ag presentation role for platelets.

Indexed as

AnimalsAntigen PresentationBlood PlateletsCD8-Positive T-LymphocytesCell MovementHistocompatibility Antigens Class IHumansLymphocyte ActivationMalariaMiceMice, Inbred C57BLPlasmodium bergheiHistocompatibility Antigens Class I

Identifiers

PMID22706078
PMCPMC3392496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.